LENZ Therapeutics share price logo

LENZ Therapeutics

NASDAQ: LENZ

$3.79

-0.05

(-1.30%)

as on

LENZ Therapeutics Stock Performance

as on October 2, 2026 at 2:15 pm IST

  • Day's High

    $3.79
    $3.91

    3.17%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.60
    $50.40
    downward going graph

    5.15%

    Downside

    1229.82%

    Upside

    downward going graph

LENZ Therapeutics share price movements today

Previous Close
$3.84
Open
$3.88
Volume
747.0K
Market Cap
$121.3M
Day's Low - High
$3.79 - $3.91
52 Week Low - High
$3.60 - $50.40

LENZ Therapeutics Historical Returns

1 Month Return
-34.66 %
3 Month Return
-35.65 %
1 Year Return
-92.16 %
3 Year Return
0 %
5 Year Return
0 %

LENZ Therapeutics Stock Fundamentals & Key Indicators

Check LENZ Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$121.3M

EPS (TTM)

-4.09

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.94

Industry PE ratio

-3.04

PEG Ratio

0.01

EBITDA

-125.5M

Revenue (TTM)

21.5M

Profit Margin

90.14%

Return On Equity TTM

-53.39%

LENZ Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LENZ Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$121.3MNA-0.9490.14%0.00%
StrongBuy$44.0B607.04%-23.170.00%0.00%
Neutral$76.9B-44.61%-24.13-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$77.3B28.74%18.1184.86%0.49%

Stock Returns calculator for LENZ Therapeutics Stock including INR - Dollar returns

The LENZ Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

LENZ Therapeutics investment value today

Current value as on today

₹8,519

Returns

-₹91,481

(-91.48%)

Returns from LENZ Therapeutics Stock

-₹92,156 (-92.16%)

Dollar Impact

₹675 (+0.68%)

Analyst Recommendation on LENZ Therapeutics Stock

Based on 5 analysts

BUY

60.00%

Buy

40.00%

Hold

0.00%

Sell

Based on 5 analysts, 60% of analysts recommend a 'BUY' rating for LENZ Therapeutics. Average target price of $24

LENZ Therapeutics Share Price Target

Get share price movements and forecasts by analysts on LENZ Therapeutics.

What analysts predicted

84.21%UPSIDE

Target Price

$24

Current Price

$3.79

Analyzed by

5 Analysts

High

$60

Target

$24.00

Low

$7

LENZ Therapeutics target price $24, a slight upside of 84.21% compared to current price of $3.79. According to 5 analysts rating.

Indian Investors' Interest in LENZ Therapeutics Stock

Search interest for LENZ Therapeutics Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

LENZ Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
5
12
1
1
5
Gross Profit
-
-
-
-
0
4
12
1
0
5
Operating Income
-16
-14
-12
-15
-16
-16
-18
-38
-44
-34
EBITDA
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Income Tax Expense
-
-
-
0
-
0
-
0
-
0
Net Income
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
99.62%
99.00%
66.94%
37.56%
94.90%

LENZ Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
15
-
-
19
Gross Profit
-
0
0
15
-
0
18
Operating Income
0
-13
-60
-10
-72
-58
-91
EBITDA
0
-68
-70
-10
-70
-49
-81
Interest Expense
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
0
-68
-70
-10
-70
-49
-81
Income Tax Expense
-
-
-
0
0
0
0
Net Income
0
-68
-70
-10
-69
-49
-82
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
96.31%

LENZ Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-16
-10
-10
-12
-14
-14
-16
-35
-41
-31
Operating Cash Flow
-23
-15
-10
-9
-16
-11
-8
-33
-33
-38
Investing Cash Flow
18
-98
-62
-11
18
0
-4
-89
33
37
Financing Cash Flow
171
-2
29
0
0
26
0
122
0
0
Change in Cash
165
-116
-42
-20
2
14
-12
0
0
0

LENZ Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-68
-70
-101
-69
-49
-82
Operating Cash Flow
0
-8
-52
-87
-60
-59
-69
Investing Cash Flow
-
-1
-5
-241
-29
-154
-75
Financing Cash Flow
-
30
417
0
80
199
149
Change in Cash
0
19
357
-329
-9
-14
4

Global Institutional Holdings in LENZ Therapeutics

Check out the Institutions with significant holdings in LENZ Therapeutics.

Funds
Holdings
Peter Kolchinsky
13.30%
Richard Gerson
11.50%
Brad Bolzon
8.46%
Fidelity Mt. Vernon Street Trust
6.07%
Vanguard
4.04%

LENZ Therapeutics News & Key Events

  • img

    Today's Timeline - 30 September

    Tue, 07:04 PM

    -

    Lenz Therapeutics announces VIZZ eye drops are now available in the U.S. for presbyopia treatment.

Insights on LENZ Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.0% return, outperforming this stock by 658.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LENZ stock has moved down by -34.7%

About LENZ Therapeutics

LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
OrganisationLENZ Therapeutics
Headquarters201 Lomas Santa Fe Drive, Solana Beach, CA, 92075, US
IndustryBiotechnology
CEOEvert Schimmelpennink

Key Management of LENZ Therapeutics

Name

Title

Mr. James W. McCollum

Co-Founder & Director

Mr. David Choromanski

Vice President of Marketing

Mr. Evert B. Schimmelpennink

President, CEO, Secretary & Director

Mr. Marc G. Odrich M.D.

Chief Medical Officer

Mr. Daniel R. Chevallard CPA

Chief Financial Officer

Mr. Domenick Porfidia

Vice President of Sales

Ms. Melissa Rosness

Senior Vice President of Manufacturing Operations

Kris Gambelin

Senior Vice President of Regulatory & Clincal Operations

Mr. Shawn Olsson

Chief Commercial Officer

FAQs

What is LENZ Therapeutics share price today?

LENZ Therapeutics share price today is $3.79 as on at the close of the market. LENZ Therapeutics share today touched a day high of $3.91 and a low of $3.79.

What is the 52 week high and 52 week low for LENZ Therapeutics share?

LENZ Therapeutics share touched a 52 week high of $50.40 on and a 52 week low of $3.60 on . LENZ Therapeutics stock price today i.e. is closed at $3.79,which is 92.48% down from its 52 week high and 5.42% up from its 52 week low.

What is LENZ Therapeutics's market capitalisation today?

LENZ Therapeutics market capitalisation is $0.00T as on .

How to invest in LENZ Therapeutics Stock (LENZ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for LENZ Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy LENZ Therapeutics Stock (LENZ) from India?

Indian investors can start investing in LENZ Therapeutics (LENZ) shares with as little as ₹96.315002441406 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.15 in LENZ Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on LENZ Therapeutics share’s latest price of $3.79 as on October 2, 2026 at 8:45 am IST, you will get 2.6385 shares of LENZ Therapeutics. Learn more about fractional shares .